Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students
Sign Up to like & getrecommendations! Published in 2021 at "Medical science educator"
DOI: 10.1007/s40670-020-01190-x
Abstract: High US drug costs have garnered increasing attention, with multiple proposed reforms. While physicians are key stakeholders, medical education about drug pricing is not described, and medical students’ understanding and attitudes are poorly understood. To… read more here.
Keywords: around drug; pricing; drug; drug pricing ... See more keywords
Response to proposal for a novel cancer drug pricing model
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-018-0062-7
Abstract: In their recent News & Views article (Sustainability and affordability of cancer drugs: a novel pricing model. Nat. Rev. Clin.Oncol. 15, 405–406 (2018))1, Uyl- De Groot and Lowenberg outline a new universal algorithm for setting… read more here.
Keywords: pricing model; drug; drug pricing; cancer ... See more keywords
Economic Evaluation of Changes in Reimbursement for Medications Purchased Through the 340B Drug Pricing Program
Sign Up to like & getrecommendations! Published in 2021 at "Hospital Pharmacy"
DOI: 10.1177/0018578719888907
Abstract: Background: The Centers for Medicare and Medicaid Services (CMS) implemented changes to the reimbursement scheme for 340B-acquired medications on January 1, 2018, reducing payments by approximately 25%. It was recognized that these changes would have… read more here.
Keywords: 340b drug; reimbursement; changes reimbursement; evaluation ... See more keywords
Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?
Sign Up to like & getrecommendations! Published in 2021 at "BMC Research Notes"
DOI: 10.1186/s13104-021-05642-4
Abstract: Objective The 340B Drug Pricing Program allows hospitals to purchase covered drugs at a discount and potentially generate profit if they are reimbursed at rates that exceed 340B acquisition prices. Disproportionate share hospitals (DSH) are… read more here.
Keywords: pricing program; drug pricing; program; 340b drug ... See more keywords
Drug Pricing Transparency: The New Retail Revolution
Sign Up to like & getrecommendations! Published in 2017 at "Hospital Pharmacy"
DOI: 10.1310/hpj5202-155
Abstract: As spending on medications in the United States increases with each passing year, the need for drug pricing transparency by manufacturers also increases. Drug spending, excluding rebates and discounts, was $309.5 billion in 2015, up… read more here.
Keywords: drug; pricing transparency; pharmacy; drug pricing ... See more keywords
Access Denied? The Unintended Consequences of Pending Drug Pricing Rules
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29040204
Abstract: The government of Canada now plans to bring into force new federal drug pricing regulations on 1 July 2022. We do not take issue with the goal of medication affordability, which is vital in healthcare… read more here.
Keywords: access; unintended consequences; drug pricing; access denied ... See more keywords